Testing effectiveness (Phase 2)Study completedNCT01807546
What this trial is testing
Oral Rigosertib for Squamous Cell Carcinoma
Who this might be right for
Head and Neck Squamous Cell CarcinomaAnal Squamous Cell CarcinomaLung Squamous Cell Carcinoma+4 more
Traws Pharma, Inc. 64